AI

There have been endless claims that AI will transform patient care, freeing up clinicians to spend time with patients and cutting costs, but many investors are wary of grandiose promises and prefer to hear the truth instead according to a session at the HIMSS & Health 2.0 European Digital Conference.

The NHS AI Lab will help facilitate the adoption of AI into clinical settings, says Indra Joshi, director of AI at the NHSX, who discusses the need for high-quality data.

The offerings, aimed at improving patient communication, have been developed by intelligent commerce and customer service software provider, Novomind MEA.

A recent survey suggests that patients value knowledge of how exactly their personal information will be used.

Sue Willman, SVP and GM of Pharmacy and Data & Analytic Services at EXL, says healthcare providers – whether addressing gaps in care, building dashboards for capacity planning or tackling fraud, waste and abuse – depend on data now more than ever.

The solution answers common questions about COVID-19 in Welsh or English.  

The UK study will enable earlier identification of infection and develop research for treatment.

The AI-integrated software can be used for early detection of COVID-19 and other diseases through imaging biomarkers in Europe.